Search

12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Xampla. Share:. Impact Insight video case study: Xampla. The first in our series of Impact Insight videos focuses on Xampla. It tells the exciting story of the research

1 Feb 2022: PneumaCare has worked closely with another of its investors, Plextek Ltd, to use 3D motion capture technology in its lead product. Read more here.

9 May 2022: Mouse monoclonal antibodies raised against Murid herpesvirus-4 (MuHV 4) developed at the University of Cambridge.

11 Apr 2022: Case study of DIOSynVax, a University of Cambridge spin-out founded by Professor Heeney, which is developing a vaccine for COVID-19.

2 Dec 2022: Creating innovative proposals which could be used to translate academic insight into a tangible real-world outcomes.

19 Jan 2022: We help University of Cambridge members commercialise their research by transforming their ideas into attractive opportunities.

18 Jan 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Science and Technology Facilities Council (STFC) Knowledge Exchange and Commercialisation (KEC) Fellowships. The KEC Fellowship scheme is designed to facilitate the development of

20 Jul 2022: We work closely with University members to help them create impact from their research through knowledge and technology transfer. 

12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: iKVA. Share:. This Impact Insight video tells the story behind the creation of iKVA. iKVA is a University of Cambridge spin-out that uses artificial intelligence (AI) to

6 Apr 2022: Cambridge Enterprise, the commercialisation arm of the University of Cambridge, announces the appointment of Dr Christine Martin as Head of Seed Funds.

9 May 2022: KARPAS 25 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge.

15 Mar 2022: The first in our new series of Impact Insight videos focuses on the exciting research commercialisation story behind Xampla.

19 Dec 2022: We have been licensing research tools for over a decade and can therefore fully support you through the process.

12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Versed AI. Share:. Impact Insight video case study: Versed AI. The second in our Impact Insight video series focuses on Versed AI. It tells the story behind the creation

9 May 2022: KARPAS 417 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge.

18 Aug 2022: International research commercialisation collaboration TenU receives £4m funding boost

23 Mar 2022: The story behind the creation of iKVA, a University of Cambridge spin-out that uses AI to facilitate knowledge management for multinationals.

12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Kalamna CIC. Share:. Impact Insight video case study: Kalamna toolkit. The third in our Impact Insight video series focuses on the licensing of the Kalamna toolkit for

9 May 2022: KARPAS 929 Human Myeloma cell line, developed at the University of Cambridge, useful in oncology research.

2 Feb 2022: University of Cambridge spin-out iKVA has secured £1.5m in seed funding to begin the rollout of its unique AI technology.